WRNA.DE vs. NUKL.DE
WRNA.DE (WisdomTree BioRevolution UCITS ETF USD Acc) and NUKL.DE (VanEck Uranium and Nuclear Technologies UCITS ETF A) are both exchange-traded funds - WRNA.DE is a Health & Biotech Equities fund tracking the WisdomTree BioRevolution ESG Screened, while NUKL.DE is a Energy Equities fund tracking the MarketVector Global Uranium and Nuclear Energy Infrastructure. Both are passively managed. Over the past 3 years, WRNA.DE returned 0.92%/yr vs 41.91%/yr for NUKL.DE. At a 0.34 correlation, their price movements are largely independent. WRNA.DE charges 0.45%/yr vs 0.55%/yr for NUKL.DE.
Performance
WRNA.DE vs. NUKL.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, WRNA.DE achieves a 10.48% return, which is significantly lower than NUKL.DE's 11.67% return.
WRNA.DE
- 1D
- 4.08%
- 1M
- 5.61%
- YTD
- 10.48%
- 6M
- 11.73%
- 1Y
- 45.11%
- 3Y*
- 0.92%
- 5Y*
- —
- 10Y*
- —
NUKL.DE
- 1D
- 0.87%
- 1M
- -4.61%
- YTD
- 11.67%
- 6M
- 4.25%
- 1Y
- 49.09%
- 3Y*
- 41.91%
- 5Y*
- —
- 10Y*
- —
WRNA.DE vs. NUKL.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
WRNA.DE WisdomTree BioRevolution UCITS ETF USD Acc | 10.48% | 9.13% | -10.92% | -7.60% |
NUKL.DE VanEck Uranium and Nuclear Technologies UCITS ETF A | 11.67% | 51.50% | 38.03% | 24.46% |
Correlation
The correlation between WRNA.DE and NUKL.DE is 0.30, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.30 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.33 |
Correlation (All Time) Calculated using the full available price history since Feb 9, 2023 | 0.34 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
WRNA.DE vs. NUKL.DE — Risk / Return Rank
WRNA.DE
NUKL.DE
WRNA.DE vs. NUKL.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for WisdomTree BioRevolution UCITS ETF USD Acc (WRNA.DE) and VanEck Uranium and Nuclear Technologies UCITS ETF A (NUKL.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| WRNA.DE | NUKL.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.54 | ||
| Sortino ratioReturn per unit of downside risk | +0.65 | ||
| Omega ratioGain probability vs. loss probability | 1.30 | 1.21 | +0.09 |
| Calmar ratioReturn relative to maximum drawdown | 3.61 | 1.86 | +1.75 |
| Martin ratioReturn relative to average drawdown | 9.63 | 4.43 | +5.20 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| WRNA.DE | NUKL.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.75 | 1.21 | +0.54 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.20 | 1.10 | -1.30 |
Drawdowns
WRNA.DE vs. NUKL.DE - Drawdown Comparison
The maximum WRNA.DE drawdown since its inception was -52.35%, which is greater than NUKL.DE's maximum drawdown of -37.52%. Use the drawdown chart below to compare losses from any high point for WRNA.DE and NUKL.DE.
Loading charts...
Drawdown Indicators
| WRNA.DE | NUKL.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -52.35% | -37.52% | -14.83% |
Max Drawdown (1Y)Largest decline over 1 year | -13.42% | -27.12% | +13.70% |
Max Drawdown (3Y)Largest decline over 3 years | -40.06% | -37.52% | -2.54% |
Current DrawdownCurrent decline from peak | -20.73% | -12.83% | -7.90% |
Average DrawdownAverage peak-to-trough decline | -27.26% | -7.79% | -19.47% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.04% | 11.43% | -6.39% |
Volatility
WRNA.DE vs. NUKL.DE - Volatility Comparison
The current volatility for WisdomTree BioRevolution UCITS ETF USD Acc (WRNA.DE) is 6.73%, while VanEck Uranium and Nuclear Technologies UCITS ETF A (NUKL.DE) has a volatility of 11.05%. This indicates that WRNA.DE experiences smaller price fluctuations and is considered to be less risky than NUKL.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| WRNA.DE | NUKL.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.73% | 11.05% | -4.32% |
Volatility (6M)Calculated over the trailing 6-month period | 17.21% | 28.97% | -11.76% |
Volatility (1Y)Calculated over the trailing 1-year period | 27.70% | 41.82% | -14.12% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 24.22% | 34.24% | -10.02% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 24.22% | 34.24% | -10.02% |
WRNA.DE vs. NUKL.DE - Expense Ratio Comparison
WRNA.DE has a 0.45% expense ratio, which is lower than NUKL.DE's 0.55% expense ratio.
Dividends
WRNA.DE vs. NUKL.DE - Dividend Comparison
Neither WRNA.DE nor NUKL.DE has paid dividends to shareholders.
Frequently Asked Questions
WRNA.DE and NUKL.DE have a correlation of 0.30, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, WRNA.DE is cheaper at 0.45% per year. The better choice depends on whether you care most about return, fees, risk, or income.
WRNA.DE is cheaper with a 0.45% expense ratio, compared with 0.55% for NUKL.DE.
WRNA.DE is categorized as Health & Biotech Equities, while NUKL.DE is Energy Equities. WRNA.DE tracks WisdomTree BioRevolution ESG Screened, while NUKL.DE tracks MarketVector Global Uranium and Nuclear Energy Infrastructure. They also come from different issuers: WisdomTree and VanEck. Their fees differ too: 0.45% for WRNA.DE and 0.55% for NUKL.DE.
Find the right allocation for WRNA.DE and NUKL.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer